As of 2024-12-15, the EV/EBITDA ratio of ChromoGenics AB (CHRO.ST) is -9.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CHRO.ST's latest enterprise value is 85.05 mil SEK. CHRO.ST's TTM EBITDA according to its financial statements is -8.66 mil SEK. Dividing these 2 quantities gives us the above CHRO.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 5.3x | 5.0x |
| Forward P/E multiples | 3.8x - 7.3x | 5.2x |
| Fair Price | (9.24) - (9.95) | (9.68) |
| Upside | -194.5% - -201.7% | -199.0% |
| Date | EV/EBITDA |
| 2024-09-30 | -9.82 |
| 2024-09-27 | -9.82 |
| 2024-09-26 | -9.79 |
| 2024-09-25 | -9.80 |
| 2024-09-24 | -9.80 |
| 2024-09-23 | -9.84 |
| 2024-09-20 | -9.77 |
| 2024-09-19 | -9.82 |
| 2024-09-18 | -9.77 |
| 2024-09-17 | -9.90 |
| 2024-09-16 | -9.79 |